Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests

5Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Background To control COVID-19 pandemic is of critical importance to the global public health. To capture the prevalence in an accurate and timely manner and to understand the mode of nosocomial infection are essential for its preventive measure. Methods We recruited 685 healthcare workers (HCW’s) at Tokyo Shinagawa Hospital prior to the vaccination with COVID-19 vaccine. Sera of the subjects were tested by assays for the titer of IgG against S protein’s receptor binding domain (IgG (RBD)) or IgG against nucleocapsid protein (IgG (N)) of SARS-CoV-2. Together with PCR data, the positive rates by these methods were evaluated. Results Overall positive rates among HCW’s by PCR, IgG (RBD), IgG (N) with a cut-off of 1.4 S/C (IgG (N)1.4), and IgG (N) with a cut-off of 0.2 S/C (IgG (N)0.2) were 3.5%, 9.5%, 6.1%, and 27.7%, respectively. Positive rates of HCW’s working in COVID-19 ward were significantly higher than those of HCW’s working in non-COVID-19 ward by all the four methods. Concordances of IgG (RBD), IgG (N)1.4, and IgG (N)0.2 against PCR were 97.1%, 71.4%, and 88.6%, respectively. By subtracting the positive rates of PCR from that of IgG (RBD), the rate of overall silent infection and that of HCW’s in COVID-19 ward were estimated to be 6.0% and 21.1%, respectively. Conclusions For the prevention of nosocomial infection of SARS-CoV-2, identification of silent infection is essential. For the detection of ongoing infection, periodical screening with IgG (RBD) in addition to PCR would be an effective measure. For the surveillance of morbidity in the population, on the other hand, IgG (N)0.2 could be the most reliable indicator among the three serological tests.

References Powered by Scopus

Characteristics of SARS-CoV-2 and COVID-19

3515Citations
N/AReaders
Get full text

SARS-CoV-2 Transmission from People without COVID-19 Symptoms

713Citations
N/AReaders
Get full text

Antibody status and incidence of SARS-CoV-2 infection in health care workers

684Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies

11Citations
N/AReaders
Get full text

Antibodies against SARS-CoV-2 S and N proteins in relapsing-remitting multiple sclerosis patients treated with disease-modifying therapies

5Citations
N/AReaders
Get full text

Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status

3Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Nishimura, M., Sugawa, S., Ota, S., Suematsu, E., Shinoda, M., & Shinkai, M. (2022). Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests. PLoS ONE, 17(5 May). https://doi.org/10.1371/journal.pone.0267566

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

50%

Professor / Associate Prof. 2

25%

Researcher 2

25%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

63%

Nursing and Health Professions 1

13%

Social Sciences 1

13%

Engineering 1

13%

Save time finding and organizing research with Mendeley

Sign up for free